Defining at‐risk populations for Parkinson's disease: Lessons from ongoing studies
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Werner Poewe(University of Verona), G. Webster Ross(VA Pacific Islands Health Care System), Kenneth Marek(University of Pennsylvania)
Cited by 128
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k